By Stewart Eisenhart, Emergo Group
Following its recent announcement of a new inspection program for medical device clinical trial sites, the China Food and Drug Administration (CFDA) has identified the first round of sites that will undergo such inspections.
Get the full story here at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MedicalDesignandOutsourcing.com or its employees.